Expres2ion Biotech AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Allan Rosetzsky, was filed 05 Mar 2018.
Expres2ion Biotech AB: what insiders have been doing
Expres2ion Biotech AB is a listed company. Filings by its managers are published through Finansinspektionen. The past year has been quiet: not a single insider filing for Expres2ion Biotech AB. The previous disclosure was published on 14 July 2020.
Since 2018, the database holds 2 purchases and 2 sales by insiders of the company.
In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Financial data
· cache
- 11,550 shares@ SEK 24.249257.1% of flowAktieISIN SE0008348262FI:csv-f3374d2c4ae644334ce5
- 25,200 shares@ SEK 6.9635.9% of flowWarrantISIN SE0008348262FI:csv-ae5b647aba07d46aa716
- 707,634 shares0FI:csv-33e133766578166adf34
- 16,800 shares@ SEK 1.264.7% of flowFI:csv-0c8ce4854f656cd2861aCanonical exit: 29 Dec 2017 (T+90)
- 8,400 shares@ SEK 1.262.3% of flowFI:csv-fb7f4f0b13ffa714cedbCanonical exit: 28 Sept 2017 (T+90)
5 of 5 declarations
About Expres2ion Biotech AB
Expres2ion Biotech AB is a biopharmaceutical company focused on developing therapies based on recombinant proteins. It is listed on the XSTO market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations